This Washington DC Lymphoma Workshop will be a virtual program to deliver live patient education programming during the coronavirus (COVID-19) outbreak. This program will still provide access to local lymphoma experts, and you can join online. Please continue to check this page for updates. For updates on digital and rescheduled programs, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation.

For LRF’s official statement on COVID-19 and LRF programs and events, please click here.

VIRTUAL – Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options

DATE:  Thursday, July 16, 2020
TIME:  9:00 AM ET – 2:30 PM ET

VIRTUAL PROGRAM – This is a virtual event, only accessible online.  Access instructions will be provided after registration. This program will be accessible for up to a month following the event so please register even if you cannot attend the day of the live event.

About The Workshop

The Lymphoma Research Foundation’s Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community across the United States. The Washington DC Lymphoma Workshop is the premier patient education and networking forum in the region.

Featuring

Bruce Cheson, MD, FACP, FAAAS, FASCO
LRF Scientific Advisory Board Member

Kieron Dunleavy, MD
George Washington University

Reasons To Attend

  • Learn about your specific type of lymphoma, treatment options, clinical trials and novel concepts during the comprehensive disease-specific breakout sessions.
  • Hear a variety of presentations and have your specific questions answered from our expert speaking faculty comprised of lymphoma specialists and patient support experts.
Program Agenda - click here

9:00 AM    Opening Remarks – Sarah Quinlan,

9:00 AM    Virtual Exhibits and Explore vFairs Lobby

9:30 AM    Welcome and LRF Overview

9:45 AM    Understanding Lymphoma Plenary Session

•  Lymphoma Overview – Kieron Dunleavy, MD, George Washington University
  Promising New Therapies – Bruce Cheson, MD, FACP, FAAAS, LRF Scientific Advisory Board Member

10:45 AM    Question and Answer Panel – Faculty: Plenary Speakers

11:15 AM    Break – Virtual Exhibits and Networking

11:30 AM    Disease-Specific Breakout Sessions

 Aggressive B-cell Non-Hodgkin Lymphoma (DLBCL/Burkitt’s Lymphoma) – Nina Wagner-Johnston, MD, Johns Hopkins
  Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma – Adrian Wiestner, MD, PhD, National Institutes of Health
  Follicular Lymphoma/Other Indolent Lymphomas (MALT/MZL) – Bruce Cheson, MD, FACP, FAAAS, LRF Scientific Advisory Board
  Hodgkin Lymphoma – Kieron Dunleavy, MD, George Washington University
  Mantle Cell Lymphoma – Craig Portell, MD, University of Virginia
  T-Cell Lymphomas (CTCL and Peripheral T-Cell) – Milos Miljković, MD, MSc, National Institutes of Health
  Waldenström Macroglobulinemia – M. Lia Palomba, MD, Memorial Sloan Kettering Cancer Center

12:30 PM    Virtual Exhibits and Networking

1:00 PM    Living With Lymphoma Breakout Sessions

 Lymphoma Survivorship – Linda A. Jacobs, PhD, RN, Hospital of the University of Pennsylvania
  Nutrition – Rachel Wong, MD, Georgetown University Hospital

2:00 PM   Workshop Concludes

To Register

VIRTUAL PROGRAM This is a virtual event, only accessible online.  Access instructions will be provided after registration. This program will be accessible for up to a month following the event so please register even if you cannot attend the day of the live event.

For additional information, please contact a member of our Lymphoma Helpline staff at helpline@lymphoma.org or (800) 500-9976.

Program Supporters

This activity is supported by educational grants from:  (see also our virtual Exhibitor Hall here)

National Presenting Supporter

Genentech

National Platinum Supporter

National Gold Supporter

pcyc_janssen_logolockup_withline_large_Janssen only_Updated January 2018

National Bronze Supporters

abbvie
AstraZeneca2
BeiGene_sml
Daiichi_Sankyo_logo
mallinckrodt-7x4
logo_sizes
TG Therapeutics Logo-revised colors.jpg